Functionally, we confirmed that OXT administration significantly elevated the levels of B3GNT7, MUC2, and fucosylation in both the AOM/DSS (Figs. S8J and S9U) and the DSS (Figs. S8K and S9V) models. The gene discussed is MUC2; the disease is infectious otitis media.